Fostamatinib Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sickle Cell DiseaseHb-SS DiseaseHemoglobin S+3 more
National Heart, Lung, and Blood Institute (NHLBI)25 enrolled1 locationNCT05904093
Recruiting
Phase 1
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
Chronic Graft Versus Host Disease
Stefanie Sarantopoulos, MD, PhD.30 enrolled1 locationNCT06233110